Latest News On U.S. Congress

Latest California Healthline Stories

Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar

The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.

What Would A Public Insurance Option Look Like In California?

California might not need one, UCLA health policy expert Gerald Kominski said in an interview — but he added that it could provide a backstop against potential future retrenchment by private sector health plans in the state’s ACA insurance exchange.